ImmPACT Bio
Camarillo
About ImmPACT Bio
ImmPACT Bio USA Inc. is a cell therapy company aiming to develop potent and selective engineered T-cells for the treatment of solid tumors. The Company's technology enables targeting loss-of-gene features of solid tumor cells, sparing normal, healthy tissues.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 101 – 250
- Estimated revenue: $1K – $10K
- Total funding: $165.9M
- Funding stage: M&A
- Last round: Grant (Feb 2024)
- Website: immpact-bio.com
Industries & Categories
Biotechnology, Life Science
Social Profiles
Canonical: https://fsome.com/organization/immpact-bio-47651 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.